[Clinical studies on S-1108 in the field pediatrics]. 1993

K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
Department of Pediatrics, Anjo Kosei Hospital.

Clinical studies on S-1108, a new oral cephem antibiotic, were carried out in the field of pediatrics. The following results were obtained. 1. The peak plasma level of S-1006 when administered after meal at a dose of 4 mg/kg was 2.47 micrograms/ml at an hour, and the serum half-life was 0.81 hour. The 4 hours urinary excretion rate of S-1006 was 35.7%. 2. S-1108 was administered to 15 children with various infections (3 patients with pneumonia, 3 with acute bronchitis, 4 with scarlet fever, 2 with acute tonsillitis, 1 with phlegmon and 2 with urinary tract infections). The overall clinical efficacy rate was 100%. 3. Side effects or abnormal laboratory test values were not observed except for diarrhea in 1 and eosinophilia in 1.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
December 1993, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
December 1993, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
November 1993, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
December 1993, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
July 1995, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
November 1993, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
November 1993, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
December 1993, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
November 1993, The Japanese journal of antibiotics,
K Kuno, and A Ogawa, and F Hayakawa, and K Ito, and M Kondo, and A Okumura, and J Natsume
November 1993, The Japanese journal of antibiotics,
Copied contents to your clipboard!